Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes

Abstract Background The histo-blood group ABO system has been associated with adverse outcomes in COVID-19, thromboembolic diseases and Plasmodium falciparum malaria. An integral part of the severe malaria pathogenesis is rosetting, the adherence of parasite infected red blood cells (RBCs) to uninfe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pontus Hedberg, Madle Sirel, Kirsten Moll, Mpungu Steven Kiwuwa, Petter Höglund, Ulf Ribacke, Mats Wahlgren
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/97aa16a7bd47439d99c9d4aa4b2545ab
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:97aa16a7bd47439d99c9d4aa4b2545ab
record_format dspace
spelling oai:doaj.org-article:97aa16a7bd47439d99c9d4aa4b2545ab2021-11-21T12:33:49ZRed blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes10.1186/s12936-021-03975-w1475-2875https://doaj.org/article/97aa16a7bd47439d99c9d4aa4b2545ab2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12936-021-03975-whttps://doaj.org/toc/1475-2875Abstract Background The histo-blood group ABO system has been associated with adverse outcomes in COVID-19, thromboembolic diseases and Plasmodium falciparum malaria. An integral part of the severe malaria pathogenesis is rosetting, the adherence of parasite infected red blood cells (RBCs) to uninfected RBCs. Rosetting is influenced by the host’s ABO blood group (Bg) and rosettes formed in BgA have previously been shown to be more resilient to disruption by heparin and shield the parasite derived surface antigens from antibodies. However, data on rosetting in weak BgA subgroups is scarce and based on investigations of relatively few donors. Methods An improved high-throughput flow cytometric assay was employed to investigate rosetting characteristics in an extensive panel of RBC donor samples of all four major ABO Bgs, as well as low BgA expressing samples. Results All non-O Bgs shield the parasite surface antigens from strain-specific antibodies towards P. falciparum erythrocyte membrane protein 1 (PfEMP1). A positive correlation between A-antigen levels on RBCs and rosette tightness was observed, protecting the rosettes from heparin- and antibody-mediated disruption. Conclusions These results provide new insights into how the ABO Bg system affects the disease outcome and cautions against interpreting the results from the heterogeneous BgA phenotype as a single group in epidemiological and experimental studies. Graphical AbstractPontus HedbergMadle SirelKirsten MollMpungu Steven KiwuwaPetter HöglundUlf RibackeMats WahlgrenBMCarticleMalariaPlasmodium falciparumRosettingHisto-blood group ABO systemArctic medicine. Tropical medicineRC955-962Infectious and parasitic diseasesRC109-216ENMalaria Journal, Vol 20, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Malaria
Plasmodium falciparum
Rosetting
Histo-blood group ABO system
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
spellingShingle Malaria
Plasmodium falciparum
Rosetting
Histo-blood group ABO system
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Pontus Hedberg
Madle Sirel
Kirsten Moll
Mpungu Steven Kiwuwa
Petter Höglund
Ulf Ribacke
Mats Wahlgren
Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes
description Abstract Background The histo-blood group ABO system has been associated with adverse outcomes in COVID-19, thromboembolic diseases and Plasmodium falciparum malaria. An integral part of the severe malaria pathogenesis is rosetting, the adherence of parasite infected red blood cells (RBCs) to uninfected RBCs. Rosetting is influenced by the host’s ABO blood group (Bg) and rosettes formed in BgA have previously been shown to be more resilient to disruption by heparin and shield the parasite derived surface antigens from antibodies. However, data on rosetting in weak BgA subgroups is scarce and based on investigations of relatively few donors. Methods An improved high-throughput flow cytometric assay was employed to investigate rosetting characteristics in an extensive panel of RBC donor samples of all four major ABO Bgs, as well as low BgA expressing samples. Results All non-O Bgs shield the parasite surface antigens from strain-specific antibodies towards P. falciparum erythrocyte membrane protein 1 (PfEMP1). A positive correlation between A-antigen levels on RBCs and rosette tightness was observed, protecting the rosettes from heparin- and antibody-mediated disruption. Conclusions These results provide new insights into how the ABO Bg system affects the disease outcome and cautions against interpreting the results from the heterogeneous BgA phenotype as a single group in epidemiological and experimental studies. Graphical Abstract
format article
author Pontus Hedberg
Madle Sirel
Kirsten Moll
Mpungu Steven Kiwuwa
Petter Höglund
Ulf Ribacke
Mats Wahlgren
author_facet Pontus Hedberg
Madle Sirel
Kirsten Moll
Mpungu Steven Kiwuwa
Petter Höglund
Ulf Ribacke
Mats Wahlgren
author_sort Pontus Hedberg
title Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes
title_short Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes
title_full Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes
title_fullStr Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes
title_full_unstemmed Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes
title_sort red blood cell blood group a antigen level affects the ability of heparin and pfemp1 antibodies to disrupt plasmodium falciparum rosettes
publisher BMC
publishDate 2021
url https://doaj.org/article/97aa16a7bd47439d99c9d4aa4b2545ab
work_keys_str_mv AT pontushedberg redbloodcellbloodgroupaantigenlevelaffectstheabilityofheparinandpfemp1antibodiestodisruptplasmodiumfalciparumrosettes
AT madlesirel redbloodcellbloodgroupaantigenlevelaffectstheabilityofheparinandpfemp1antibodiestodisruptplasmodiumfalciparumrosettes
AT kirstenmoll redbloodcellbloodgroupaantigenlevelaffectstheabilityofheparinandpfemp1antibodiestodisruptplasmodiumfalciparumrosettes
AT mpungustevenkiwuwa redbloodcellbloodgroupaantigenlevelaffectstheabilityofheparinandpfemp1antibodiestodisruptplasmodiumfalciparumrosettes
AT petterhoglund redbloodcellbloodgroupaantigenlevelaffectstheabilityofheparinandpfemp1antibodiestodisruptplasmodiumfalciparumrosettes
AT ulfribacke redbloodcellbloodgroupaantigenlevelaffectstheabilityofheparinandpfemp1antibodiestodisruptplasmodiumfalciparumrosettes
AT matswahlgren redbloodcellbloodgroupaantigenlevelaffectstheabilityofheparinandpfemp1antibodiestodisruptplasmodiumfalciparumrosettes
_version_ 1718418958804058112